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As leading opportunistic fungal pathogens identification and subtyping of Candida species are crucial in recognizing outbreaks of
infection, recognizing particularly virulent strains, and detecting the emergence of drug resistant strains. In this study our objective
was to compare identification of Candida albicans by the hospitals through the use of conventional versus identification based on
the ITS (Internal Transcribed Spacer) and to assess biofilm forming capabilities, drug resistance patterns and correlate these with
MLST typing. ITS typing revealed a 21.2% hospital misidentification rate. Multidrug resistance to three drugs out of four tested
was detected within 25% of the isolates raising concerns about the followed treatment regimens. Drug resistant strains as well
as biofilm formers were phylogenetically related, with some isolates with significant biofilm forming capabilities being correlated
to those that were multidrug resistant. Such isolates were grouped closely together in a neighbor-joining tree generated by MLST
typing indicating phylogenetic relatedness,microevolution, or recurrent infection. In conclusion, this pilot study givesmuchneeded
insight concerningC. albicans isolates circulating in Lebanese hospitals and is the first study of its kind correlating biofilm formation,
antifungal resistance, and evolutionary relatedness.
1. Introduction
As the leading opportunistic fungal pathogen Candida infec-
tions have increased significantly worldwide, with the species
C. albicans responsible for most of these infections [1–3].
Over the past two decades, Candida species have become the
leading pathogens responsible for nosocomial bloodstream
infections with C. albicans causing more than 50% of these
infections [4]. C. albicans, a dimorphic commensal yeast, has
two reservoirs: the patients’ normal flora and the environ-
ment. Both interact making it difficult to block transmission
of the pathogen between patients [5]. Infections range from
superficial, affecting the skin, mouth, and vagina, to sys-
temic associated with high morbidity and mortality rates in
immunosuppressed individuals, HIV patients, chemotherapy
patients, and organ transplant patients [6].
Virulence of C. albicans can be attributed to several
factors such as phenotypic switching, dimorphic transition
between hyphae and yeast, adhesins, and secretion of pro-
teases and phospholipases [7, 8]. The ability of C. albicans
to dimorph between two main shapes, a round budding
yeast and an elongated parallel-walled true hypha (with
an intermediary, pseudohyphal form consisting of stretched
ellipsoid cells), is the basis of the germ tube test utilized in
most hospitals to identify C. albicans from other Candida
species (C. dubliniensis being the exception as it can form
true hyphae) [6]. Biofilm formation is another important
aspect of C. albicans pathogenesis. This phenomenon allows
Candida to adhere to mucosal cells and to plastic surfaces
of medical devices such as catheters and dentures leading to
device associated infections and eventually spreading noso-
comial infections. Biofilm forming cells are phenotypically
different from floating cells in that they are embedded in a
three-dimensional structure and can proliferate in healthy
individuals surviving within the immune system of the host
and having an increased resistance to antifungal drugs [8, 9].
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Treatment of Candida infections in general and C. albi-
cans in particular is limited to the availability of classes
and number of antifungal drugs. Only four major classes
of antifungal drugs are currently available including the
most commonly used azoles, polyenes, fluoropyrimidines,
and the newly generated echinocandins. The latter is used as
an alternative for isolates showing resistance to the former
antifungal drugs [10, 11].
As infections caused by C. albicans increased worldwide,
identification became a must. Conventional methods are
unable to identify yeast species within an acceptable error
range [12]. As such molecular typing methods were devel-
oped including restriction fragment length polymorphisms
(RFLP), pulsed-field gel electrophoresis (PFGE), multilocus
sequence typing (MLST), and Internal Transcribed Spacer
(ITS) sequencing [3, 10].
Overall, antifungal drug resistance (ADR) and fungal
virulence characteristics such as biofilm formation are critical
issues for the host-pathogen relationship in candidiasis.
However, very little is known about the relationship between
drug resistance and virulence of C. albicans [13]. In this
study 85 isolates were collected from two major hospitals
in Beirut/Lebanon between June and October 2011. Isolates
were identified using API, germ tube, CHROMagar, and ITS
sequencing. Furthermore, antifungal susceptibility testing
against four antifungal drugs was performed, and the isolates
were additionally tested for biofilm formation followed by
MLST typing for selected isolates to determine the epidemi-
ological relatedness of the isolates.
2. Materials and Methods
2.1. Clinical Isolates. A total of 85 clinical Candida isolates
collected between June 2010 and October 2011 (16 months)
were kindly provided by two major hospitals in Beirut. For
the sake of confidentiality the hospitals will be referred to
as hospital “A” and hospital “B.” Thirty-one samples (36.4%)
were recovered from urine, 23 samples (27.1%) from sputum,
12 samples (14.2%) from tracheal aspirates, 11 samples (12.9%)
from bronchial lavages, three samples (3.5%) from body
fluids, two samples (2.3%) from abscesses, two samples
(2.4%) from puss swabs, and one sample (1.2%) from an
abdominal swab. 56.4% (𝑛 = 48/85) of the patients were
females while 43.6% (𝑛 = 37/85) were males (range from
two years to 92 years old). Samples were classified by both
hospitals as either C. albicans or C. non-albicans.
Germ tube, a test that shows the ability of the isolates
to germinate inside a tube, was performed for all the 85
samples. Following three hours of incubation in serum at
37∘C, samples were examined under the microscope for
their ability to germinate. An isolate is designated as C.
albicans only if it appeared filamentous upon visualization.
The samples were streaked on Potato Dextrose Agar (PDA)
and stored in cryobank vials at −80∘C until use.
2.2. Samples Identification Using Color Forming Candida
CHROMagar. Clinical isolates were cultured on color
forming Candida CHROMagar, the CandiSelect 4 (Bio-Rad,
Hercules, CA, USA), and incubated at 28∘C for 24–48 h
according to the manufacturer’s instructions. Candida
species are then identified according to the color of the
colony.
2.3. Samples Identification Using API 20 C AUX. Fresh
colonies were collected after culturing on PDA for 48 h at
28∘C. The API 20 C AUX (bioMe´rieux, France) kit was used
according to the manufacturer’s instructions. Results were
collected after 48 and 72 h, respectively. Results were analyzed
manually following the manufacturer’s instructions or using
the apiweb software (bioMe´rieux, France).
2.4. DNA Extraction. For DNA extraction, fresh colonies
were collected upon culturing the samples on PDA for 48 h at
28∘C. Extraction was performed using the NucleoSpin Tissue
(Macherey-Nagel, Germany) kit according to the manufac-
turer’s instructions. Lyticase (Sigma, USA) and sorbitol buffer
(1.2M sorbitol, 10mM calcium chloride, 0.1M Tris/Cl pH of
7.5, and 35mM 𝛽-mercaptoethanol) were added in the lysis
step to weaken the chitin cell wall. The extracted DNA was
then stored at −20∘C until needed.
2.5. Typing of the ITS Gene. Amplification of the Internal
Transcribed Spacer regions ITS 1 and ITS 4 was accom-
plished by adding 2 𝜇L of the sample DNA lysate, 0.4 𝜇L
(20 pmol/𝜇L) of each 5󸀠-TCCGTAGGTGAACCTGCGG-
3󸀠 (forward) and 5󸀠-TCCTCCGCTTATTGATATGC-3󸀠
(reverse), 9.7𝜇L deionized water, and 12.5 𝜇L (250U) of the
AmpliTaq Gold PCR Master Mix (Applied Biosystems) [11].
The PCR thermal cycling conditions were 95∘C for 12min,
30 cycles of 95∘C for 30 s, 54∘C for 30 s, and 72∘C for
100 s, and a final extension at 72∘C for 10min. 0.5𝜇L of
Exonuclease I (Thermo Scientific) and 1 𝜇L of Fast Alkaline
Phosphatase (Thermo Scientific) were added to 6 𝜇L of
presequencing PCR product in order to purify it.The thermal
conditions for this step were 37∘C for 15min followed by
80∘C for 15min. ABI Prism BigDye Terminator v3.0 Ready
Reaction Cycle Sequencing Kit (Applied Biosystems) was
used to sequence the purified PCR product. The sequencing
reaction was performed by adding 4𝜇L of 5 X-diluted
BigDye premix, 3𝜇L of 1.2 𝜇M sequencing forward/reverse
primers, and 3 𝜇L of the purified PCR product. PCR cycle
was performed, consisting of initial denaturation step at 96∘C
for 1min followed by 26 cycles of 96∘C for 10 s, 50∘C for 5 s,
and 60∘C for 4min. BigDye X-Terminator Purification Kit
(Applied Biosystems)was used to purify sequencing products
according to the manufacturer’s instructions. Sequencing
plate was then loaded for sequencing electrophoresis on
an ABI 3500 Avant Genetic Analyzer (Applied Biosystems).
For sequence analysis, the CLC Main Workbench software
v5.0 (CLC bio, Denmark) was used to assemble and align
sequences and consensus sequences obtained were compared
to ITS sequences in the GenBank database using BLASTn at
the National Center for Biotechnology Information website
( http://blast.ncbi.nlm.nih.gov/Blast.cgi).
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2.6. MLST. Thirty samples were chosen to be additionally
typed using MLST. The 30 samples chosen where ITS iden-
tified as C. albicans. MLST was performed by amplification
of 7 housekeeping genes (AAT1a, ACC1, ADP1, MPIB, SYA1,
VPS13, and ZWF1B) as described by Shin et al. [14]. CLC
Main Workbench software v5.0 (CLC bio, Denmark) was
used to assemble and align sequences of the seven house-
keeping genes and sequence types (STs) were determined by
submitting the allelic profile of representative alleles to the
MLST database (http://calbicans.mlst.net/).
2.7. Antifungal Susceptibility Testing. Antifungal susceptibil-
ity to 4 antifungal drugs, azoles (fluconazole and posacona-
zole), echinocandins (anidulafungin), and polyenes (ampho-
tericin B), was performed. The minimum inhibitory con-
centrations (MICs) were determined using 𝐸-test strips
(bioMe´rieux, France) following CLSI standards except for
posaconazole and amphotericin B. No definite MIC was pro-
vided for posaconazole; accordingly MIC was determined as
that of fluconazole since it belongs to the same category, while
for amphotericin B theMIC used was 0.38 ug/mL [10]. RPMI
1640 with MOPS, glucose L-glutamine but no bicarbonate
(AB Biodisk, bioMe´rieux, France) was the media of choice
when performing the antifungal susceptibility testing. Media
were prepared according to the manufacturer’s instructions.
After culturing of the samples in Potato Dextrose Broth
(PDB), fungal suspension with 0.5 McFarland turbidity (or
105 CFU/mL) was used to streak on the RPMI media. The
strips were applied on the inoculated plate and incubated at
37∘C for 48 h. C. albicans ATCC 90028 was used as a quality
control.
2.8. Biofilm Formation Assay. Biofilm formation assay was
performed on all 85 samples. Each sample was done in
triplicate and the average was determined. Three to four
colonies were suspended in YNB (Yeast Nitrogen Base, Fluka,
Switzerland) and incubated overnight with gentle shaking.
The optical density of each of the suspensions was adjusted
to 0.65 [15]. 0.5mL of the suspension was added to a flat-
bottomed microtiter well (24-well plates, pretreated with 5%
fetal bovine serum (BioWhittaker, Belgium)) at 4∘C and
placed in a shaker at 37∘C for 3 h to allow for initial adhesion.
Plates were then washed with 0.5mL PBS buffer and another
0.5mL of the cell suspension was added. Following 48 h
incubation at 37∘C, cells were washed with 1mL PBS and
fixed using 0.5mL of 99% methanol for 15min. Plates were
then allowed to air-dry for 20min. Staining was performed
by adding 0.2% crystal violet, removed after 20min, and
followed by 0.75mL of 33% acetic acid. The absorbance
was immediately measured using a spectrometer (Thermo
Spectronic) at 590 nm [15].C. albicans strain SC5314 was used
as a reference strain.
2.9. Statistical Analysis. To determine statistical significance
of the biofilm study, both a 𝑡-test and a post hoc ANOVA
test were carried out. For the ANOVA test isolates were
grouped into 3 groups: those with biofilm capabilities below
the reference strain, those similar to the reference strain,
and those above the reference strain. Statistical significance
with the reference strain group was observed for both groups
containing isolates above and below the reference strain (data
not shown). A 𝑃 value below 0.05 was deemed significant.
3. Results
3.1. Germ Tube versus API and CHROMagar. C. albicans is
primarily identified in hospitals using germ tube formation.
The germ tube test was repeated on all 85 samples, and our
results matched the hospital identification. Based on germ
tube testing, 62 samples (72.9%) were hospital-identified as
C. albicans, 22 samples (25.9%) were identified as Candida
non-albicans, and one sample (1.1%) was unidentifiable and
needed further identification through typing.
For isolation and differentiation of major clinically sig-
nificant Candida species, CHROMagar and API were used.
Results showed that eight samples (9.4%) streaked onCHRO-
Magar showed different identification than that shown using
the germ tube test. On the other hand, 11 samples (12.9%) of
those tested by API also did not match the germ tube results,
while two samples (2.3%) did not show amatch between germ
tube testing when compared to the API and CHROMagar.
3.1.1. ITS Sequencing. Eighty-five samples were ITS
sequenced. Results showed that 69 (81.1%) isolates were
C. albicans, eight (9.4%) were C. glabrata, six (7%) were
C. tropicalis, and one (1%) isolate belonged to Pichia spp.
Among the C. albicans isolates, 18 samples (21.1%) were
misidentified by the germ tube test, 13 samples (15.2%) were
misidentified using cultivation on CHROMagar, and 13
(15.2%) were misidentified by API. Table 1 summarizes the
comparison between germ tube, API, CHROMagar, and ITS
sequencing for those isolates showing discrepancies. The
ITS sequences obtained in this study were aligned and a
neighbor-joining tree was generated to monitor the clusters
(Figure 1). The non-albicans species aligned together in two
clusters apart from each other: one cluster containingmost of
the C. glabrata isolates and another that included most of the
C. tropicalis ones. This indicated that ITS sequence in some
C. albicans isolates has higher homology to non-Candida
isolates than to those that belong to the same species. Leaw
et al. showed that sequence analysis of the ITS region could
not identify phylogenetically related species and uncommon
yeast [11]. Typing of this region will tend to differentiate the
isolates into major subclasses due to conserved sequences
[10]. Also, isolates from hospitals A and B did not cluster
together.
3.2. MLST. Out of the 85 ITS typed samples, 30 samples
were chosen to be additionally typed using MLST. The
30 samples chosen were ITS-identified as C. albicans. The
samples were chosen from each ITS cluster shown in Figure 1
and MLST was performed in order to compare between
MLST and ITS neighbor-joining trees to determine whether
ITS typing alone could be used to reflect strain relatedness.
Moreover, the sequences of the seven housekeeping genes
were concatenated into a single sequence and aligned against
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Figure 1: ITS neighbor-joining tree of all isolates collected. “+” denotes isolates that had biofilm forming capabilities above reference strain
SC5314. AND, POS, FL, and AP refer to the antifungal drugs, anidulafungin, posaconazole, fluconazole, and amphotericin B, respectively.
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Table 1: Discrepancy in identification rates. Table encompasses the 22 isolates that were differentially identified by the four identification
methods used.
Sample ID Germ tube (hospitalidentification) Germ tube CHROMagar API ITS Antifungal resistance
∗ Biofilm
IB001 Typing needed − Unidentifiable C. sphaerical Pichia spp. AP, POS −
IB016 C. albicans + C. albicans C. albicans C. glabrata AND, POS, FL −
IB019 Non-albicans − C. glabrata C. glabrata C. albicans POS, FL −
IB026 Non-albicans − C. glabrata C. glabrata C. albicans POS, FL −
IB028 C. albicans + C. albicans C. albicans C. tropicalis POS, FL −
IB029 C. albicans + C. tropicalis C. tropicalis C. tropicalis AP −
IB030 C. albicans + C. tropicalis C. tropicalis C. albicans POS, FL −
IB060 Non-albicans − C. albicans C. albicans C. albicans FL, AP −
IB063 Non-albicans − C. tropicalis C. tropicalis C. albicans POS, FL, AP +
IB064 C. albicans + C. albicans C. albicans C. tropicalis POS, FL +
IB067 Non-albicans − C. albicans C. albicans C. albicans POS, FL +
IB068 Non-albicans − C. albicans C. albicans C. albicans AP +
IB070 Non-albicans − C. glabrata C. glabrata C. albicans POS, FL −
IB071 Non-albicans − C. tropicalis C. tropicalis C. glabrata POS, FL, AP +
IB072 Non-albicans − C. albicans C. albicans C. albicans POS, FL −
IB077 Non-albicans − C. albicans C. albicans C. albicans Sensitive to all −
IB078 C. albicans + C. glabrata C. glabrata C. glabrata POS, AP +
IB080 Non-albicans − White color C. lusitaniae C. tropicalis FL, AP −
IB081 Non-albicans − C. glabrata C. glabrata C. tropicalis AP −
IB083 Non-albicans − C. albicans C. albicans C. albicans POS, FL −
IB086 Non-albicans − C. albicans C. albicans C. albicans FL, AP −
IB097 Non-albicans − C. glabrata C. glabrata C. albicans POS, FL, AP −
∗AND: anidulafungin, AP: amphotericin B, FL: fluconazole, and POS: posaconazole. Biofilm “−” refers to strains that form biofilm at a rate lower than the
reference strain SC5314, while biofilm “+” refers to strain that forms biofilm at a higher rate than the reference strain.
the other samples. The neighbor-joining tree was applied as
shown in Figure 2. The 30 MLST typed samples did not have
any ST representation on the website http://www.mlst.net.
The sequences will be submitted to the creator of the online
database, and new STs will be assigned. Four couples of
isolates, IB083 and IB070, IB106 and IB024, IB093 and IB103,
and IB095 and IB002, had a bootstrap value of 100 indicating
their close relatedness. All other bootstrap values (with two
exceptions) were above 50 implying a high level of confidence
within the clades.
3.3. Antifungal Susceptibility Testing. Isolates were tested for
antifungal susceptibility against the four antifungal drugs
using the𝐸-test. Fifty-nine isolates (69.5%) showed resistance
against fluconazole followed by 54 being (63.5%) resis-
tant against posaconazole and 32 (37.6%) resistant against
amphotericin B. Although anidulafungin is a new antifungal
agent, resistance was detected in ten of the isolates (11.7%)
(Figure 3). Multidrug resistance was also considered, with 21
samples out of the 85 (25%) showing resistance against at least
three antifungal agents (Figure 3). There was no statistically
significant correlation between drug resistance and isolate
location, or between resistance and hospital source. Most of
the resistance isolates did come from urine samples, but since
urine was the largest reservoir of isolates obtained, such a
correlation is not significant.
3.4. Biofilm Formation. As can be seen in Figure 4, seventeen
samples (20%) showed biofilm formation above levels of the
wild-type reference strain SC5314 and were deemed to be
strong biofilm formers.The𝑃 value was calculated using both
Student’s 𝑡-test and post hoc ANOVA test and was deemed
significant if <0.05. No correlation between biofilm forming
capabilities and hospitals was found. However correlation
between biofilm, drug resistance, and phylogenetic related-
ness was observed; isolates IB063 and IB074, which clustered
together, were recovered from the same hospital and were
strong biofilm formers and multidrug resistant.
4. Discussion
Identification of Candida at the species level is considered
critical to provide proper treatment to severely ill patients
[16]. In this study, 85 isolates of Candida species were col-
lected from two major hospitals in Beirut/Lebanon between
June and October 2011. Urine (36.4%) represented the main
source of the collected isolates. Urinary tract is the main
source of nosocomial infections and Candida species is
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the most common species among fungi recovered from urine
[17], which was in harmony with our results.
Hospital identification of Candida species is based on the
germ tube test that differentiates between C. albicans and
Candida non-albicans. The germ tube is a rapid and cheap
identification test of C. albicans that can be completed in 90–
180min. Germ tube formation is considered a pathogenicity
factor in C. albicans [18]. Germ tube was performed on all
85 samples in an attempt to replicate the hospital results.
This test is not considered an accurate test since it relies
solely on phenotypic changes. Some Candida non-albicans
species share similar features to that found in C. albicans,
such as C. dubliniensis which also forms germ tube in
serum. This fact contributes to misidentification incidences
reported when germ tube is solely considered in hospitals
[19]. Moreover, C. africana can also produce germ tube in
serum and would be misidentified as C. albicans [20]. Such
false-positive results might lead to the use of inappropriate
antifungal agents especially that different Candida species
have different innate primary resistance to antifungal drugs,
resulting in hospitalization of the patient for a longer period
of time. Yazbek et al. reported misidentification rate of 24%
by the germ tube testing compared to real-time PCR for
isolates collected from four major hospitals in Beirut, which
was comparable to the 21.2%misidentification rates observed
in this study [21].
Another conventional identification method that is being
used is CHROMagar. This medium relies on the ability of
different Candida species to form pigmented colonies due
to the breakdown of substrates by enzymes of the fungus
resulting in the change of color [16]. It is a selective and
differential method for direct identification and isolation
[22]. In this study, four out of all the tested isolates showed
discrepancies in identification results between germ tube and
CHROMagar; three identified as C. albicans by the germ
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tube were identified as C. tropicalis (two samples) and C.
glabrata (one sample) by CHROMagar, and one identified as
C. non-albicans using germ tube was identified as C. albicans
on CHROMagar.These results showed that identification by
these two methods can be contradictory and additionally
emphasizes the need for alternative identification methods.
A study in France revealed that C. tropicalis is considered the
main, but not exclusive, source of false-positive identifica-
tions on chromogenic media [23], while Eraso et al. reported
misidentification using CHROMagar and presence of both
false-positive and false-negative results [16].
On the other hand, four of the isolates identified as C.
albicans according to the hospital records were found to be
C. tropicalis, C. glabrata, and C. sphearical based on API
results, five identified as C. non-albicans were C. albicans,
and one isolate not identifiable neither by CHROMagar
nor by the hospital was identified as C. sphaerical. This
method is considered reliable in the sense of sensitivity, but
it is time consuming as some isolates are slow growers and
will need 72 h for confirmation of the results [24]. Studies
showed that the sensitivity of this method in identifying
common yeast isolates was 96.3% with 66% identification
for unconventional yeast isolates. Most studies confirmed the
need for other identification methods along with the API
based system to avoid errors and misidentifying isolates [24].
To assess the feasibility of using those conventional
methods, we have sequenced the ITS gene of all isolates.
ITS sequencing showed that conventional methods gave
8 BioMed Research International
in many instances contradictory and inaccurate results. The
sequence-based methods have been used for identification
of Candida species and considered to be accurate and fast
[9].Moreover, sequence-based identification techniqueswere
found to be more efficient than other phenotypic methods,
and sequence analysis of the ITS region provided a higher
percent of accurate identification [25]. Furthermore, a study
conducted in UK showed that ITS sequencing was able to
accurately identify isolates such as C. africana that could not
be properly identified by conventional methods [20].
MLST was performed on 30 samples chosen from each
major subclass generated by ITS sequencing. In contrast to
ITS, MLST is based on sequence analysis of seven unrelated
genes that are not conserved [26]. A neighbor-joining tree
was generated for the samples typed and compared to that
of the ITS. The relatedness of the samples differed in each
tree. Tavanti et al. showed that MLST could be used for
epidemiological studies due to its high discriminatory power
among closely related species and isolates and the high repro-
ducibility which other techniques lack [26]. Additionally,
C. albicans isolates might undergo microevolution, which
means that the same isolate can undergo a small variation in
its genome to adapt to some situations such as resistance to
antifungal drugs. These small changes in the genome would
be very difficult to be recognized using typical sequenc-
ing techniques. MLST can identify these microevolutionary
changes to elucidate the source of the transmission of the
isolate and the evolutionary events in outbreaks or recurrent
infections. MLST could be used for epidemiological studies
whereas ITS sequencing is accurate for species identification
only. The sequences of the 30 samples typed were submitted
to the database (http://www.mlst.net) to assign the diploid
sequence type (DST); however, they could not be identified
by the database. The sequences will be sent to the database
curators to assign new DSTs and add these sequences to the
database.
Biofilm forming ability is an important factor that con-
tributes to virulence of a pathogen. All 85 isolates were tested
for biofilm formation, and 17 (20%) showed the ability to
form biofilm at a higher rate than the reference strain SC
5314. These results were correlated to the ITS and MLST
neighbor-joining trees to determine whether these isolates
would cluster together. There was no observed correlation
between ITS clusters and biofilm formation, while MLST
clustered the six biofilm forming isolates (all from the same
hospital) close to each other. Samples IB069 and IB070 are
located in a subcluster with significant bootstrap value, while
IB109, IB077, IB063, and IB074 are located in the same
subcluster close to one another indicating that these samples
share homology and sequence similarity. This correlation
has never been shown before between a virulence trait and
MLST sequence types. As such, this is an interesting finding
whereby, in theory, virulence attributes for uncharacterized
isolates could be predicted by MLST clustering.
Susceptibility to antifungal drugs was determined and the
results revealed that 59 of the isolates (69.5%) were resistant
to fluconazole, 54 (63.5%) to posaconazole, and 32 (37.6%)
to amphotericin B. There was a significant difference from
what was previously reported by Basma et al. in a study
conducted in Lebanon on antifungal susceptibility of 116 C.
albicans hospital isolates [10]. The percentage of fluconazole
(FL) resistance was 5.2% and 12.1% for IT (itraconazole).
The resistance for the azole and especially FL has increased
enormously perhaps due to uncontrolled use and overusage.
On the other hand, the reported resistance by Basma et al. for
amphotericin B (AP) was 1.7%, while in this study it was 38%,
a 22-fold increase in five years [10].These results indicated the
rapid increase in the resistance for AP in clinical isolates even
though usage is limited due to toxicity. The study done by
Basma et al. also determined resistance against caspofungin
(CS), which belongs to the most recent antifungal class of
drugs, and results revealed that all of the tested isolates
were susceptible [10]. However, in this study resistance
to anidulafungin (AND), belonging to the same class of
antifungals, was 11.9%. This showed again the emergence of
resistance against this new class of antifungals. Additionally,
25% of the samples were resistant to three antifungals and
above with two of the samples being multidrug resistant.
The high misidentification rates can explain the high rate of
drug resistance, sincemisidentification leads to inappropriate
antifungal treatment. MLST grouped the resistant strains
next to each other implying high sequence relatedness such
as that seen with IB085, IB014, and IB105, located next to one
another, and with IB063, IB018, and IB074. Only IB090 was
found in another independent cluster. These findings show
that resistant strains were phylogenetically related.
Interestingly, there was a correlation between antifungal
susceptibility and biofilm formation since IB074 and IB063
(both collected from hospital B) had both of these features.
Candida cells growing in a biofilm are known to be highly
resistant to antifungal drugs through different mechanisms
including active extrusion through efflux pumps [27]. These
two samples, however, were related based on MLST typ-
ing indicating that they shared homology in more than
one aspect, implying a possible case of microevolution of
one strain and possible dissemination into another patient.
Interestingly however IB063 as opposed to IB074 was not
resistant to anidulafungin, which might be explained by
microevolution resulting in loss/gain of drug resistance.
However, since only two isolates exhibited such correlation
and in light of the relatively low number of isolates that were
sequenced by MLST, such a correlation cannot be further
substantiated.
5. Conclusion
In conclusion this study has shown that the germ tube
test method used by most hospitals is fairly inaccurate in
identifying Candida species and as such either a combination
of conventional methods or the use of molecular sequencing
methods should be used. Such a high misidentification rate
has resulted in unacceptably high rates of drug resistance,
an issue that should be immediately addressed. Further-
more, this study is the first of its kind that attempts to
correlate between strain relatedness, drug resistance, and a
virulence attribute such as biofilm formation and found that
most resistant strains grouped together. The drawbacks of
BioMed Research International 9
this study are the relatively small number of samples and
the lack of patient clinical history, which precluded any
discussion of nosocomial infection.
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